WHO: Evidence is lacking for clinical effectiveness of Xevudy and Regen-Cov against the COVID-19 variants that are currently circulating.
SGLT-2 inhibitors and drugs to treat HFrEF were compared for efficacy in patients with HF with LVEF ≥40%.
The new consensus recommends holistic, person centered care focused on glycemic and weight management, CV risk reduction, and cardiorenal organ protection.
Data from the CDC on US vaccination and booster shot rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Adolescents with severe obesity who underwent bariatric surgery before age 22 lost 31.1% body weight and kept it off over a decade later, showed new study.
New survey findings suggest the need for more in-depth conversations with patients about benefits and harms of newer oral therapies for type 2 diabetes.
Hospital admissions among patients with T2D taking basal insulin only were reduced by 67% one year after beginning treatment with the CGM system.
Adults with migraine with aura were found at significantly greater risk for AF and those younger than age 55 years were particularly vulnerable, write Mayo Clinic investigators.
Average patient wait time for a nonemergent appointment with an FP decreased between 2017 and 2020, according to a Merritt Hawkins survey. Is that a good sign?
Approximately one-third of CV-related ED visits are for hypertension-related conditions, including 13% for essential hypertension among women.